MSP008-22
Sponsors
Godavari Biorefineries Limited
Conditions
Advanced Solid TumorCOVID-19
Phase 1
Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours
CompletedNCT05478486
Start: 2023-02-01End: 2026-01-23Updated: 2026-02-04
Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers
CompletedNCT05532293
Start: 2022-12-02End: 2025-11-10Updated: 2026-02-03